Teva Stock Falls After Earnings and Revenue Miss Estimates | Barron's
Teva earnings Q2 2018 | AlphaStreet
Teva Q2 Earnings: 5 Reasons Why Shares Rose By 30% (NYSE:TEVA) | Seeking Alpha
Earnings season continues: BMS revenue inches up, Teva lowers outlook
Teva Pharmaceuticals Q4 2016 Earnings
Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt - MarketWatch
Q3 pharma earnings roundup: Moderna, Regeneron and Teva
TEVA Stock | Teva Pharmaceutical Industries Ltd Q3 2021 Earnings Call - YouTube
Teva Pharmaceutical falls 6% on eve of Q3 earnings show | Seeking Alpha
Teva Pharmaceuticals on Twitter: "Our live Q2 2022 earnings call is starting soon! Join President & CEO Kåre Schultz to discuss Teva's business performance and plans ahead. Join here: https://t.co/VR9FyBqEz2 #QuarterlyResults #Earnings $
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Teva Pharmaceutical Is in Recovery - WSJ
Earnings Preview: What To Expect From Teva Pharmaceutical On Thursday
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva Pharmaceutical Industries L Up 24.16% To $8.90 After Earnings Beat
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations - Simply Wall St News
Teva Pharmaceutical earnings per share 2006-2021 | Statista
Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva tumbles as sales and earnings underwhelm
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror – PharmaLive
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
Here's Why Teva Shares are Trending Higher Today
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
